Sumatriptan Tablet Franchise in Ahmedabad

Anti-Migraine Tablet Supplier in Mumbai

Migraine Treatment Tablet Distributor in Delhi

Neurology PCD Pharma Franchise in Bangalore

Sumatriptan Tablet Stockist in Hyderabad
Anti-Migraine Tablet Manufacturer & Exporter in Chandigarh

Home/Products /sumatriptan-25mg-tablet

Sumapan 25 Tablet

Composition : Sumatriptan (25mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Sumapan 25 Tablet contains Sumatriptan 25mg, a low-dose anti-migraine agent used for acute migraine attacks with or without aura, particularly suitable for patients requiring milder initial dosing. It helps in relieving migraine symptoms such as headache, nausea, and sensitivity to light or sound.

Sumatriptan works by selectively stimulating serotonin (5-HT1) receptors, which causes constriction of cranial blood vessels and inhibition of inflammatory neuropeptide release. This mechanism provides rapid and effective relief during migraine episodes.

This tablet is especially suitable for patients who require low-dose intervention, making it ideal for sensitive populations or those with moderate migraine attacks. Its oral dosage ensures convenience and better compliance in outpatient therapy.

For PCD pharma franchise partners, Sumapan 25 Tablet is a high-demand neurology product, available at the best price for PCD pharma franchise. Its proven clinical effectiveness, consistent prescription trends, and growing migraine patient base make it an essential addition to any neuro-care product portfolio.


Read More

About the Product

Sumapan 25 Tablet contains Sumatriptan 25mg, a low-dose anti-migraine agent used for acute migraine attacks with or without aura, particularly suitable for patients requiring milder initial dosing. It helps in relieving migraine symptoms such as headache, nausea, and sensitivity to light or sound.

Sumatriptan works by selectively stimulating serotonin (5-HT1) receptors, which causes constriction of cranial blood vessels and inhibition of inflammatory neuropeptide release. This mechanism provides rapid and effective relief during migraine episodes.

This tablet is especially suitable for patients who require low-dose intervention, making it ideal for sensitive populations or those with moderate migraine attacks. Its oral dosage ensures convenience and better compliance in outpatient therapy.

For PCD pharma franchise partners, Sumapan 25 Tablet is a high-demand neurology product, available at the best price for PCD pharma franchise. Its proven clinical effectiveness, consistent prescription trends, and growing migraine patient base make it an essential addition to any neuro-care product portfolio.


Common side effects include dizziness, drowsiness, tingling sensations, flushing, tightness in the chest or throat, and mild nausea. Rare but serious effects may include heart rhythm changes, elevated blood pressure, or severe allergic reactions.

Sumapan 25 Tablet is indicated for the acute treatment of migraine with or without aura in adults. It may also be prescribed for managing cluster headaches under medical supervision.

Sumapan 25 Tablet should be taken only as directed by a healthcare professional and used only at the onset of a migraine attack. It is not meant for preventive treatment. Patients with heart disease, stroke, uncontrolled hypertension, or vascular disorders should avoid use unless advised by a doctor.

Store Sumapan 25 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation